Caribou Biosciences Appoints Tim Kelly as Chief Technology :

-- Tim Kelly to lead Caribou’s technical operations strategy and execution -- -- CB-010 ANTLER Phase 1 trial initial dose expansion data and RP2D to be...

Related Keywords

Berkeley , California , United States , Sydney , New South Wales , Australia , Westmead , Peggy Vorwald , Sundar Jagannath , Sriram Krishnaswami , Stephen Schuster , Kenneth Micklethwaite , Margarita Louis Dreyfus , Tim Kelly , Samy Figueroa , Rachel Haurwitz , Oxford Biomedica Solutions , United States Air Force Academy , Caribou Biosciences Inc , Penn Medicine Abramson Cancer Center , Us Air , Homology Medicines Inc , Exchange Commission , University Of Sydney , Tisch Cancer Institute Of Mount Sinai , University Of Pennsylvania , Pfizer Oncology Global Product Development , Drug Administration , Troy State University , Prior To Oxford Biomedica Solutions , Pfizer , Perelman School Of Medicine , Nasdaq , Lify Phase , Healthcare Conference , Homology Medicines , United States Air Force , Regenerative Medicine Advanced Therapy , Fast Track , Orphan Drug , Westmead Hospital , Reigin Zawadzki , Perelman School , Penn Medicine , Abramson Cancer , Multiple Myeloma , Tisch Cancer Institute , Pfizer Oncology , Global Product Development , Caribou Biosciences , Private Securities Litigation Reform Act , Annual Report , Nasdaq Crbu , Nc , Cart Cell Therapies , Rispr , Antler , Ammouflage , Amplify ,